Tenax Therapeutics (TENX) Revenue: 2010-2016
Historic Revenue for Tenax Therapeutics (TENX) over the last 2 years, with Dec 2016 value amounting to $1,507.
- Tenax Therapeutics' Revenue was N/A to $1,507 in Q4 2016 from the same period last year, while for Dec 2016 it was $1.9 million, marking a year-over-year change of. This contributed to the annual value of -$23,000 for FY2024, which is 4.17% up from last year.
- Latest data reveals that Tenax Therapeutics reported Revenue of $1,507 as of Q4 2016, which was up 164.26% from -$2,345 recorded in Q2 2015.
- Tenax Therapeutics' 5-year Revenue high stood at $1.7 million for Q2 2013, and its period low was -$2,345 during Q2 2015.
- For the 2-year period, Tenax Therapeutics' Revenue averaged around -$419, with its median value being -$419 (2015).
- Data for Tenax Therapeutics' Revenue shows a peak YoY soared of 1,644.98% (in 2013) over the last 5 years.
- Quarterly analysis of 4 years shows Tenax Therapeutics' Revenue stood at $514,872 in 2012, then surged by 1,644.98% to $1.7 million in 2013, then reached -$2,345 in 2015, then reached $1,507 in 2016.
- Its last three reported values are $1,507 in Q4 2016, -$2,345 for Q2 2015, and $1.7 million during Q2 2013.